BioSpace News Archive

Rubius Therapeutics, Inc. (Nasdaq: RUBY), today announced that it has signed a purchase and sale agreement for the acquisition of a 135,000-square foot manufacturing facility located in Smithfield, Rhode Island.

Designed with Exclusive New Features for Bi-Directional Electronic Medical Records Integration Including Auto-Programming and Auto-Documentation

New Directions Behavioral Health announced plans to move its headquarters from Kansas City, Missouri to the Sprint campus in Overland Park, Kansas. The company recently finalized terms of the new lease, which will begin in April 2019.

July 25, 2018 17:43 UTC LONDON--( BUSINESS WIRE )-- Technavio has announced their latest pipeline analysis report on the spinal muscular atrophy market . The report includes a detailed analysis of the pipeline molecules under investigation within the defined data collection period to treat spinal muscular atrophy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/201807250

MEDISCA will be the North American Distributor of Highly Reliable New SAMIX® Product Line

Technavio has announced their latest pipeline analysis report on the polymyositis market. The report includes a detailed analysis of the pipeline molecules under investigation within the defined data collection period to treat polymyositis.

MichBio applauds yesterday’s passage by the U.S. House of Representatives of H.R. 184 – The Protect Medical Innovation Act of 2017.

Torque the appointment of James Mullen as Chairman of the Board of Directors, Maykin Ho, PhD, as Strategic Advisor to the Board of Directors, and Mario Sznol, MD, to the Scientific Advisory Board.

GT Biopharma Inc. announced the addition of Dr. John N. Bonfiglio to GT Biopharma’s Board of Directors on July 5, 2018.

Tolero Pharmaceuticals, Inc. announced that the first patient has been dosed in a Phase 1 study evaluating investigational agent TP-0184